Dr. Gruneich was most recently a World Wide Provider Solution Sales specialist in IBM Healthcare and Life Sciences, focused on translational medicine. He worked with government, pharmaceutical, biotechnology, and academic clients to identify and implement IT systems to help them accomplish their business and strategic goals. Prior to joining IBM, Dr. Gruneich was Chief Business Officer of Infoceutics, Inc., an anti-microbial bioinformatics company. He also co-founded and was Chief Strategy Officer for eTechtransfer.com, an online exchange for licensing life science intellectual property. He worked as a research scientist developing new immunodiagnostic tests for Charm Sciences.

Dr. Gruneich received his PhD in Bioengineering from the University of Pennsylvania, developing new gene therapy technologies.

Mr. Greenman most recently led the strategic marketing function for Philips Medical System’s Remote Patient Management Division, part of Philip’s New Ventures organization. In this role, Mr. Greenman was responsible for commercialization and partnership strategy for a disease management platform technology. Prior to Philips, Mr. Greenman was Director of Business Development for Ardais Corporation, a biorepository management company offering software technology as well as a library of human biospecimens and molecular services for drug discovery. Mr. Greenman was the founder of medXtend Corporation, a venture backed healthcare services company providing medical devices and services for use by Radiologists and Primary Care Physicians. Additionally, Mr. Greenman worked in a variety of healthcare consulting roles within Accenture’s Healthcare Practice, KPMG Peat Marwick’s Healthcare Strategy Group, Oracle, and the Boston Consulting Group.

Mr. Greenman holds an MBA from the Wharton School of Business in Healthcare Management.